Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM
ConditionType II Diabetes Mellitus
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age30-85
SponsorFr Muller Homoeopathic Medical College
About this trial
Objective: To ascertain whether homoeopathic medicine ABROMA AUGUSTA has a clinical role in changing the Glycated Hb Level in Diabetes mellitus Type II.
Abstract:
Background: Type 2 diabetes mellitus (T2DM) is one of the most important epidemic diseases in the world in this century, and accounts for 90% of cases of diabetes globally. Studies have suggested that Abroma Augusta plays a role in acute controlling blood glucose level. The aim of this study was to evaluate the efficacy of "Abroma Augusta Ѳ" in chronic control through GlycatedHb (HbA1c %) in Diabetes Mellitus Type 2 (NIDDM) as a pretest post-test study.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patient with major complications like diabetic retinopathy and cardiomyopathy. IDDM HbA1c above 11%
Trial design
Treatments tested in this trial
- Abroma Augusta Q (mother tincture)
Treatment groups
No treatment groups listed
Locations
1,Father Muller Homoeopathic Medical College, Prasanth Nivas Ashram Nmpt Hospital575002, MangaloreKarnataka, India
Sponsors and collaborators
Fr Muller Homoeopathic Medical College
Lead sponsor
Source ClinicalTrials.gov